REQUEST A DEMO
Total
USD $0.00
Search more companies

Bioleaf Pharma Bis Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: All Other Food Manufacturing | Chemical and Allied Products Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Pharmacies and Drug Stores | Department Stores | Other Activities Related to Credit Intermediation | Rental and Leasing Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Bioleaf Pharma Bis Sp. z o.o. Profile Updated: April 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Bioleaf Pharma Bis Sp. z o.o. is an enterprise based in Poland. Its main office is in Warsaw. The company operates in the Pharmaceutical Preparation Manufacturing sector. It was first established on April 17, 2018. During that time, Bioleaf Pharma Bis Sp. z o.o.’s total assets decreased by 12.32%.

Headquarters
Ul. Zlota 61/100
Warsaw; Mazowieckie; Postal Code: 00-819

Contact Details: Purchase the Bioleaf Pharma Bis Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Bioleaf Pharma Bis Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Bioleaf Pharma Bis Sp. z o.o. report to view the information.
Incorporation Date:
April 17, 2018
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Bioleaf Pharma Bis Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
-61.08%
Net Profit (Loss) for the Period
-61.08%
Total assets
-12.32%
Total equity
-15.99%
Return on Equity (ROE)
-9.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?